Related Experiment Video
Updated: Apr 14, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Molecular mechanisms of myocarditis caused by Trypanosoma cruzi
Lísia Esper1, André Talvani, Pollyana Pimentel
1aDepartment of Biochemistry and Immunology bInstitute of Biological Sciences and Program in Health Sciences: Infectious Diseases and Tropical Medicine, Medical School, Federal University of Minas Gerais, Belo Horizonte cDepartment of Biological Sciences and Center for Research in Biological Science (NUPEB), Federal University of Ouro Preto, Minas Gerais, Brazil.
Insights
Chagas disease, caused by Trypanosoma cruzi, leads to lifelong inflammation and organ damage, particularly cardiac issues. Understanding parasite strategies and host defenses is key to managing this growing global health concern.
Area of Science:
- Infectious Diseases
- Immunology
- Parasitology
Background:
- American trypanosomiasis (Chagas disease) is a persistent infection by Trypanosoma cruzi, a major cause of illness in South and Central America.
- Increased global migration and transmission risks (blood transfusion, organ transplant) are expanding Chagas disease prevalence in Europe and the USA.
- The pathology involves a sustained inflammatory response, parasite elimination attempts, and tissue damage.
Purpose of the Study:
- To review current knowledge on Trypanosoma cruzi persistence strategies.
- To examine host defense mechanisms against Trypanosoma cruzi infection.
- To understand factors influencing disease development versus asymptomatic equilibrium.
Main Methods:
- Review of existing literature on Chagas disease pathogenesis.
- Analysis of parasite "strategies" for host survival.
- Evaluation of host immune responses and their outcomes.
Main Results:
- Chronic inflammation drives biochemical, physiological, and morphological changes in cardiac, nervous, and digestive systems.
- Clinical manifestations include myocarditis, arrhythmias, heart failure, and autonomic dysfunction.
- The complex interplay between parasite and host immunity in disease initiation and progression remains debated.
Conclusions:
- Host-parasite interactions determine outcomes ranging from asymptomatic infection to severe cardiac disease.
- Understanding these dynamics is crucial for developing effective therapeutic and preventative strategies.
- Further research is needed to elucidate the precise mechanisms of Chagas disease pathogenesis.
Purpose Of Review:
American trypanosomiasis, or Chagas disease, is a lifelong and persistent infection caused by the protozoan Trypanosoma cruzi and is the most significant cause of morbidity and mortality in South and Central America. Owing to immigration and additional risks from blood transfusion and organ transplantation, the number of reported cases of Chagas disease has increased recently in Europe and the USA. The disease is caused by a moderate to intense lasting inflammatory response that triggers local expression of inflammatory mediators and activates and recruits leukocytes to various tissues to eliminate the parasites.
Recent Findings:
This long-term inflammatory process triggers biochemical, physiological and morphological alterations and clinical changes in the digestive, nervous and cardiac (e.g. myocarditis, arrhythmias, congestive heart failure, autonomic dysfunctions and microcirculatory disturbances) systems. Indeed, the pathogenesis of Chagas disease is intricate and multifactorial, and the roles of the parasite and the immune response in initiating and maintaining the disease are still controversial.
Summary:
In this review, we discuss the current knowledge of 'strategies' employed by the parasite to persist in the host and host defence mechanisms against Trypanosoma cruzi infection, which can result in equilibrium (absence of the disease) or disease development, mainly in the cardiac systems.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Mechanism of Cardiac Arrhythmias
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

